Oxford Handbook of Oncology
Price: 1199.00 INR
ISBN:
9780198847175
Publication date:
27/10/2025
Paperback
752 pages
180x100mm
Price: 1199.00 INR
ISBN:
9780198847175
Publication date:
27/10/2025
Paperback
752 pages
Fifth Edition
Edited by Miranda Payne, Semini Greening, Robert Owens, Rebecca Shakir, Victoria Woodcock, and Gareth Morris-Stiff
Forthcoming title
- Written by experts in the field to ensure all advice is grounded in real-life clinical practice
- Concise and comprehensive, with areas of controversy highlighted and further reading provided throughout
- Contains a step by step guide to common oncological emergencies
- Includes evidence-based medicine and additional further reading
New to this Edition:
- Incorporates changes such as the understanding of the science of cancer
- Includes novel therapies in breast, lung, renal, and melanoma, as well as molecular sub-classification of common solid cancers, and personalized therapy approaches
- Provides information for new agents in hard to treat cancers, and the benefits of new technologies in radiotherapy
- Reflects the increasing role of immunotherapy and targeted anti-cancer therapies
Rights: OUP UK (INDIAN TERRITORY)
Fifth Edition
Edited by Miranda Payne, Semini Greening, Robert Owens, Rebecca Shakir, Victoria Woodcock, and Gareth Morris-Stiff
Description
Now fully revised and in its fifth edition, the Oxford Handbook of Oncology has been the essential go-to guide for students, junior doctors, and medical professionals embarking on a career in oncology for over two decades. The handbook includes an introduction to the scientific basis and diagnosis of cancers, as well as drugs, biomarkers, and the presentation and psychosocial aspects of oncology. Concise, practical, and comprehensive, there is no better companion for both common conditions and challenging emergencies.
The field of oncology has surged forward since the last edition was published and the Oxford Handbook of Oncology has been fully revised and updated to reflect these recent advances so you can be sure that the vital information you need is in your hands. This handbook incorporates changes such as the understanding of the science of cancer, novel therapies in breast, lung, renal, and melanoma, molecular sub-classification of common solid cancers, personalized therapy approaches, new agents in hard to treat cancers, the benefits of new technologies in radiotherapy, and the increasing role of immunotherapy and targeted anti-cancer therapies.
Written by experts in the field to ensure that it is grounded in real life clinical practice, this handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding.
About the editors
Miranda Payne is a previous CRUK Clinical Fellow and a current Consultant in Medical Oncology at the Oxford University Hospitals NHS Foundation Trust. Recruitment to international, academic, industry-sponsored and observational clinical trials is a routine aspect of Miranda's clinical practice, reflected in her publication record. She has a particular interest in the consequences of immunotherapy and in the systemic treatment of melanoma. She has been an editor of the Oxford Handbook of Oncology for over 20 years.
Robert Owens is a consultant clinical oncologist in Oxford where he also completed his oncology training. He specialises in treating GI cancers and has a specific interest in focussed targeted radiotherapy (SABR) especially in the upper GI setting.
Gareth Morris Stiff is an accomplished surgical oncologist with 32 years of postgraduate experience with specific expertise in hepato-pancreato-biliary (HPB) cancers, and a Pharma key opinion leader in exocrine pancreatic insufficiency. Extensive research portfolio and widely published in peer-reviewed journals. Numerous leadership roles directing teams and committees within the clinical and research arenas up to a national level. Departed clinical practice to develop anti-cancer therapies with a portfolio including antibodies, small molecules, Ayurvedic-western hybrids, and phytomedicines. Currently global chief medical officer for Equilibrium Labs developing phytomedicines to aid metabolism dysfunction-associated fatty liver disease and cancer chemotherapy-related adverse events.
Victoria Woodcock is a consultant in medical oncology specialising in the treatment of colorectal cancer. She completed her oncology training in Oxford and undertook a DPhil in Oncology at the University of Oxford studying immune responses to checkpoint inhibitor treatment in melanoma. Her academic interests include understanding and augmenting immune responses against cancer through conducting clinical trials of novel immunotherapy treatments and translational research.
Dr Rebecca Shakir is a clinical oncology consultant at the Churchill Hospital in Oxford and post-doctoral academic visitor at Oxford Population Health. Alongside treating people with head and neck and skin cancer, she specialises in the management of people with the long-term side-effects of cancer treatment. Her research focuses on determining the benefits and risks of radiotherapy and shared decision making. In addition to her clinical work, Rebecca is the Sherrington Lecturer at Magdalen College Oxford and a member of the Specialty Training and Professional Standards Boards at the Royal College of Radiologists.
Contributors:
Arfon G M T Powell
Consultant Oesophagogastric & General Surgeon, Salford Royal Foundation Trust, UK
Lara Hawkes
Consultant in Cancer Genetics, Oxford University Hospitals NHS Foundation Trust, UK
Aisling Barrett
Clinical Research Fellow in Haematology, Oxford University Hospitals NHS Foundation Trust, UK
Fifth Edition
Edited by Miranda Payne, Semini Greening, Robert Owens, Rebecca Shakir, Victoria Woodcock, and Gareth Morris-Stiff
Table of contents
1. The Multidisciplinary approach to cancer
2. Modifiable risk factors for cancer
3. Genetics of cancer
4. Cancer prevention
5. Population screening for cancer
6. Principles of surgical oncology
7. Principles of radiation oncology
8. Introduction to principles of SACT
9. Principles of chemotherapy
10. Principles of immunotherapy and gene therapy
11. Principles of targeted and biological therapies
12. Hormone therapy
13. Biomarkers
14. Novel therapeutic approaches and clinical trials
15. Late effects of treatment for cancer
16. Principles of symptom control in palliative care
17. Thoracic malignancies
18. Breast cancer
19. Colorectal cancer
20. Anal cancer
21. Upper gastrointestinal cancer
22. Endocrine cancers
23. Genitourinary cancers
24. Gynaecological cancers
25. Head and neck cancers
26. Tumours of the central nervous system
27. Melanoma and other skin cancers
28. Haematological malignancies
29. Bone and soft tissue malignancies
30. Malignancy of unknown primary
31. Paraneoplastic syndromes
32. Childhood cancers presenting in adults
33. Oncology emergencies
Fifth Edition
Edited by Miranda Payne, Semini Greening, Robert Owens, Rebecca Shakir, Victoria Woodcock, and Gareth Morris-Stiff
Fifth Edition
Edited by Miranda Payne, Semini Greening, Robert Owens, Rebecca Shakir, Victoria Woodcock, and Gareth Morris-Stiff
Fifth Edition
Edited by Miranda Payne, Semini Greening, Robert Owens, Rebecca Shakir, Victoria Woodcock, and Gareth Morris-Stiff
Description
Now fully revised and in its fifth edition, the Oxford Handbook of Oncology has been the essential go-to guide for students, junior doctors, and medical professionals embarking on a career in oncology for over two decades. The handbook includes an introduction to the scientific basis and diagnosis of cancers, as well as drugs, biomarkers, and the presentation and psychosocial aspects of oncology. Concise, practical, and comprehensive, there is no better companion for both common conditions and challenging emergencies.
The field of oncology has surged forward since the last edition was published and the Oxford Handbook of Oncology has been fully revised and updated to reflect these recent advances so you can be sure that the vital information you need is in your hands. This handbook incorporates changes such as the understanding of the science of cancer, novel therapies in breast, lung, renal, and melanoma, molecular sub-classification of common solid cancers, personalized therapy approaches, new agents in hard to treat cancers, the benefits of new technologies in radiotherapy, and the increasing role of immunotherapy and targeted anti-cancer therapies.
Written by experts in the field to ensure that it is grounded in real life clinical practice, this handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding.
About the editors
Miranda Payne is a previous CRUK Clinical Fellow and a current Consultant in Medical Oncology at the Oxford University Hospitals NHS Foundation Trust. Recruitment to international, academic, industry-sponsored and observational clinical trials is a routine aspect of Miranda's clinical practice, reflected in her publication record. She has a particular interest in the consequences of immunotherapy and in the systemic treatment of melanoma. She has been an editor of the Oxford Handbook of Oncology for over 20 years.
Robert Owens is a consultant clinical oncologist in Oxford where he also completed his oncology training. He specialises in treating GI cancers and has a specific interest in focussed targeted radiotherapy (SABR) especially in the upper GI setting.
Gareth Morris Stiff is an accomplished surgical oncologist with 32 years of postgraduate experience with specific expertise in hepato-pancreato-biliary (HPB) cancers, and a Pharma key opinion leader in exocrine pancreatic insufficiency. Extensive research portfolio and widely published in peer-reviewed journals. Numerous leadership roles directing teams and committees within the clinical and research arenas up to a national level. Departed clinical practice to develop anti-cancer therapies with a portfolio including antibodies, small molecules, Ayurvedic-western hybrids, and phytomedicines. Currently global chief medical officer for Equilibrium Labs developing phytomedicines to aid metabolism dysfunction-associated fatty liver disease and cancer chemotherapy-related adverse events.
Victoria Woodcock is a consultant in medical oncology specialising in the treatment of colorectal cancer. She completed her oncology training in Oxford and undertook a DPhil in Oncology at the University of Oxford studying immune responses to checkpoint inhibitor treatment in melanoma. Her academic interests include understanding and augmenting immune responses against cancer through conducting clinical trials of novel immunotherapy treatments and translational research.
Dr Rebecca Shakir is a clinical oncology consultant at the Churchill Hospital in Oxford and post-doctoral academic visitor at Oxford Population Health. Alongside treating people with head and neck and skin cancer, she specialises in the management of people with the long-term side-effects of cancer treatment. Her research focuses on determining the benefits and risks of radiotherapy and shared decision making. In addition to her clinical work, Rebecca is the Sherrington Lecturer at Magdalen College Oxford and a member of the Specialty Training and Professional Standards Boards at the Royal College of Radiologists.
Contributors:
Arfon G M T Powell
Consultant Oesophagogastric & General Surgeon, Salford Royal Foundation Trust, UK
Lara Hawkes
Consultant in Cancer Genetics, Oxford University Hospitals NHS Foundation Trust, UK
Aisling Barrett
Clinical Research Fellow in Haematology, Oxford University Hospitals NHS Foundation Trust, UK
Table of contents
1. The Multidisciplinary approach to cancer
2. Modifiable risk factors for cancer
3. Genetics of cancer
4. Cancer prevention
5. Population screening for cancer
6. Principles of surgical oncology
7. Principles of radiation oncology
8. Introduction to principles of SACT
9. Principles of chemotherapy
10. Principles of immunotherapy and gene therapy
11. Principles of targeted and biological therapies
12. Hormone therapy
13. Biomarkers
14. Novel therapeutic approaches and clinical trials
15. Late effects of treatment for cancer
16. Principles of symptom control in palliative care
17. Thoracic malignancies
18. Breast cancer
19. Colorectal cancer
20. Anal cancer
21. Upper gastrointestinal cancer
22. Endocrine cancers
23. Genitourinary cancers
24. Gynaecological cancers
25. Head and neck cancers
26. Tumours of the central nervous system
27. Melanoma and other skin cancers
28. Haematological malignancies
29. Bone and soft tissue malignancies
30. Malignancy of unknown primary
31. Paraneoplastic syndromes
32. Childhood cancers presenting in adults
33. Oncology emergencies
Dr Phillip Molloy
Oxford Handbook for the Foundation Programme - Sixth Edition
Tim Raine, George Collins, Fraser Brown, and Sophie Howarth
Oxford Handbook of Respiratory Medicine - Fourth Edition
Stephen J Chapman, Grace V Robinson, Rahul Shrimanker, Chris D Turnbull & John M Wrightson
Dignity in Care: The Human Side of Medicine
Harvey Max Chochinov
Oxford Handbook of Medical Education in Practice
Edited by Gabrielle Finn, Megan Brown, Matthew Byrne, Helen Church & Neel Sharma
Handbook of Renal Transplantation
Georgi Abraham & Anusha Rohit
Peter Lachman, Jane Runnacles, Anita Jayadev, John Brennan, and John Fitzsimons
Nick James
